Editorial: USA missing opportunities for HPV vaccination

The Lancet Infectious Diseases
Sep 2013  Volume 13  Number 9   p725 – 822

USA missing opportunities for HPV vaccination
The Lancet Infectious Diseases
Since the US Advisory Committee for Immunization Practices (ACIP) recommended vaccination to protect against human papillomavirus (HPV) for girls at age 11–12 years, year-on-year increases in vaccine uptake have been disappointingly small. Data from the National Immunization Survey-Teen (NIS-Teen) show that the proportion of girls age 13–17 years who had received one dose of the vaccine increased from 25·1% in 2007 to just 53·0% in 2011. Despite substantial improvement in coverage in the early years, this slowed, and worryingly new figures released on July 26 indicate that uptake has stalled, with coverage at 53·8% in 2012.